CIPLA
Back to Income Statement
|
CIPLA Last 5 Year Total Expenditure History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Expenditure | ₹19,483 Cr | ₹17,763 Cr | ₹17,251 Cr | ₹14,911 Cr | ₹13,951 Cr |
What is the latest Total Expenditure of CIPLA ?
| Year | Total Expenditure |
|---|---|
| Mar2025 | ₹19,483 Cr |
| Mar2024 | ₹17,763 Cr |
| Mar2023 | ₹17,251 Cr |
| Mar2022 | ₹14,911 Cr |
| Mar2021 | ₹13,951 Cr |
How is Total Expenditure of CIPLA Trending?
| Years | Total Expenditure | % Change | |
|---|---|---|---|
| Mar2025 | ₹19,483 Cr | 9.68 | |
| Mar2024 | ₹17,763 Cr | 2.96 | |
| Mar2023 | ₹17,251 Cr | 15.70 | |
| Mar2022 | ₹14,911 Cr | 6.88 | |
| Mar2021 | ₹13,951 Cr | - | |
Compare Total Expenditure of peers of CIPLA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| CIPLA | ₹97,848.8 Cr | 0.8% | -9.1% | -13.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹407,083.0 Cr | -3.9% | -8.9% | -3.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹163,971.0 Cr | 3.8% | -4.7% | 11.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹140,660.0 Cr | 3.2% | -5.6% | 26.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹101,686.0 Cr | 3.3% | -6% | 11% | Stock Analytics | |
| MANKIND PHARMA | ₹87,624.9 Cr | 1.9% | -7.1% | -15.2% | Stock Analytics | |
CIPLA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| CIPLA | 0.8% |
-9.1% |
-13.1% |
| SENSEX | 3.7% |
-0.9% |
0.7% |
You may also like the below Video Courses